Pages that link to "Q48375029"
Jump to navigation
Jump to search
The following pages link to Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process (Q48375029):
Displaying 50 items.
- Benign Multiple Sclerosis: A Distinct Clinical Entity with Therapeutic Implications (Q22252834) (← links)
- Interferon beta for secondary progressive multiple sclerosis (Q24203879) (← links)
- Personalized medicine in multiple sclerosis: hope or reality? (Q27025933) (← links)
- The topographical model of multiple sclerosis: A dynamic visualization of disease course (Q27312133) (← links)
- A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives (Q28068709) (← links)
- The mechanism of action of interferon-β in relapsing multiple sclerosis (Q28239752) (← links)
- Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis (Q28246535) (← links)
- EFNS guideline on treatment of multiple sclerosis relapses: report of an EFNS task force on treatment of multiple sclerosis relapses (Q28284851) (← links)
- The immunopathology of multiple sclerosis: an overview (Q28295115) (← links)
- The retrovirus/superantigen hypothesis of multiple sclerosis (Q30317136) (← links)
- Walking impairment in patients with multiple sclerosis: exercise training as a treatment option (Q30433850) (← links)
- A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology (Q30525646) (← links)
- Clinical, MRI, and CSF markers of disability progression in multiple sclerosis. (Q30712257) (← links)
- Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis (Q30983016) (← links)
- The role of MRI in the evaluation of secondary progressive multiple sclerosis. (Q31033345) (← links)
- Sex hormones: a role in the control of multiple sclerosis? (Q31037759) (← links)
- Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study (Q31081056) (← links)
- Relapse rates in patients with multiple sclerosis treated with fingolimod: Subgroup analyses of pooled data from three phase 3 trials. (Q31117462) (← links)
- Subcutaneous interferon β-1a may protect against cognitive impairment in patients with relapsing-remitting multiple sclerosis: 5-year follow-up of the COGIMUS study (Q31141962) (← links)
- Time-series modeling of multiple sclerosis disease activity: a promising window on disease progression and repair potential? (Q33289264) (← links)
- Estimating Time to Event From Longitudinal Categorical Data: An Analysis of Multiple Sclerosis Progression (Q33392874) (← links)
- MRI characteristics are predictive for CDMS in monofocal, but not in multifocal patients with a clinically isolated syndrome (Q33449002) (← links)
- Getting the balance right: a randomised controlled trial of physiotherapy and Exercise Interventions for ambulatory people with multiple sclerosis (Q33483034) (← links)
- Intrathecal synthesis of oligoclonal IgM against myelin lipids predicts an aggressive disease course in MS. (Q33565842) (← links)
- Real-life walking impairment in multiple sclerosis: preliminary comparison of four methods for processing accelerometry data (Q33599581) (← links)
- Effect of catalpol on remyelination through experimental autoimmune encephalomyelitis acting to promote Olig1 and Olig2 expressions in mice. (Q33630050) (← links)
- Adherence to disease-modifying therapies and its impact on relapse, health resource utilization, and costs among patients with multiple sclerosis (Q33638157) (← links)
- Geographic variations of multiple sclerosis prevalence in France: The latitude gradient is not uniform depending on the socioeconomic status of the studied population. (Q33692773) (← links)
- Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US survey (Q33719214) (← links)
- Cognitive impairments in relapsing-remitting multiple sclerosis: a meta-analysis (Q33761190) (← links)
- Impact of multiple sclerosis relapses on progression diminishes with time (Q33898204) (← links)
- The impact of multiple sclerosis onset symptom on cardiac repolarization (Q33917429) (← links)
- 17beta-estradiol protects male mice from cuprizone-induced demyelination and oligodendrocyte loss (Q33938006) (← links)
- Evidence for a two-stage disability progression in multiple sclerosis (Q33944184) (← links)
- The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability (Q33944200) (← links)
- Clinical characteristics of multiple sclerosis in Kuwait: data from the new MS registry of Amiri Hospital. (Q34045441) (← links)
- Gender effect on neurodegeneration and myelin markers in an animal model for multiple sclerosis (Q34138065) (← links)
- Long term benefit of multiple sclerosis treatment: an investigation using a novel data collection technique (Q34288517) (← links)
- Lessons for clinical trials from natalizumab in multiple sclerosis (Q34367044) (← links)
- Aggressive multiple sclerosis: proposed definition and treatment algorithm (Q34478828) (← links)
- Sex differences in autoimmune diseases (Q34498866) (← links)
- What went wrong in the natalizumab trials? (Q34499681) (← links)
- Secondary progressive multiple sclerosis: current knowledge and future challenges (Q34503137) (← links)
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing--remitting multiple sclerosis: subgroup analyses from the phase 2b study (Q34631940) (← links)
- Benign multiple sclerosis: does it exist? (Q34640135) (← links)
- Body fluid biomarkers in multiple sclerosis: how far we have come and how they could affect the clinic now and in the future (Q35078327) (← links)
- Adult gonadal hormones selectively regulate sexually dimorphic quantitative traits observed in experimental allergic encephalomyelitis (Q35083316) (← links)
- Radiologically isolated syndrome: 5-year risk for an initial clinical event (Q35112019) (← links)
- Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review (Q35126308) (← links)
- Predictive value of imaging markers at multiple sclerosis disease onset based on gadolinium- and USPIO-enhanced MRI and machine learning. (Q35137514) (← links)